29.12.2014 Views

AIDS post-HIV : beat of a different drummer - AltHeal

AIDS post-HIV : beat of a different drummer - AltHeal

AIDS post-HIV : beat of a different drummer - AltHeal

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

andomly received oral N-acetylcysteine (median<br />

4.4 g/d; range 3.2-8 g/d) or placebo. After 8 wks.,<br />

pts. could elect to take open label NAC for an<br />

additional period (median=6 mo.). NAC re s t o re d<br />

decreased whole blood glutathione levels. Pts. with<br />

very low CD4 cell counts who took NAC survived<br />

roughly twice as long as those who did not.<br />

[ H e r z e n b e rg LA et al. Glutathione deficiency is<br />

associated with impaired survival in <strong>HIV</strong> disease.<br />

Proc Natl Acad Sci 94:1967-72, 1997].<br />

High Sugar Consumption Effects on Immune<br />

Function<br />

7 healthy adults ingested 75 gm glucose. In vitro<br />

lymphocyte transformation in response to PHA at<br />

30 and 60 min. was significantly depressed to<br />

79.4% and 83.3% <strong>of</strong> fasting levels, respectively. At<br />

2 hrs., lymphocyte transformation had returned to<br />

fasting levels. Addition <strong>of</strong> physiologic doses <strong>of</strong><br />

insulin decreased in vitro lymphocyte transformation<br />

by 40%. Results suggest that glucose ingestion<br />

may affect in vitro measures <strong>of</strong> cellular<br />

immunity by increasing serum insulin, which<br />

competes with mitogens for binding sites on<br />

lymphocytes. In addition, glucose may impair cellmediated<br />

immunity in vivo [Bernstein J et al.<br />

Depression <strong>of</strong> lymphocyte transformation following<br />

oral glucose ingestion. Am J Clin Nutr 30:613,<br />

1977].<br />

Intestinal Permeability (‘Leaky Gut’)<br />

This study evaluated intestinal permeability by<br />

using a lactulose- mannitol diff e rential intestinal<br />

permeability test in healthy controls, <strong>HIV</strong>- p o s i t i v e<br />

patients without symptoms, and <strong>AIDS</strong> patients with<br />

and without diarrhea. The <strong>AIDS</strong> patients with<br />

diarrhea had significant alterations in intestinal<br />

permeability with increased lactulose recovery and<br />

decreased mannitol recovery, and their mean lactulose:mannitol<br />

ratio was significantly greater than<br />

the ratio in all other groups. The authors conclude<br />

that patients with <strong>AIDS</strong> and diarrhea have altere d<br />

intestinal permeability. The reduced absorption <strong>of</strong><br />

mannitol suggests there is a decreased functional<br />

absorptive surface in the intestines <strong>of</strong> <strong>AIDS</strong><br />

patients as their disease pro g resses. The term<br />

intestinal permeability refers to how the lining <strong>of</strong><br />

the intestines allows molecules to pass through by<br />

nonmediated effusion. The mannitol re c o v e r y<br />

showed an incremental decrease in the 3 <strong>HIV</strong>positive<br />

groups, suggesting that as <strong>HIV</strong> progresses<br />

t h e re is a loss <strong>of</strong> functional absorptive surface.<br />

Glutamine is an essential amino acid for the gut<br />

lining and has been shown to improve intestinal<br />

permeability and reverse villous atrophy in human<br />

and animal models. [Intestinal Permeability in<br />

Patients Infected With Human Immunodeficiency<br />

Virus. Te p p e r, Robert E., M.D., et al, American<br />

J o u rnal <strong>of</strong> Gastro e n t e ro l o g y, 1994;89(6):878-882.<br />

Address: Douglas Simon, M.D., Director, Division <strong>of</strong><br />

G a s t ro e n t e ro l o g y, Jacobi Hospital, Room 303B,<br />

Bronx Municipal Hospital Center, Pelham Parkway<br />

and Eastchester Rd., Bronx, NY 10461, U.S.A.]<br />

Iron Deficiency and Cell-Mediated Immunity<br />

When iron is deficient, cell-mediated immunity is<br />

impaired, especially when the deficiency is associated<br />

with a vitamin E deficiency [Chandra RK.<br />

Trace element regulation <strong>of</strong> immunity and infection.<br />

J Am Coll Nutr 4(1):5-16, 1985].<br />

Iron Deficiency and Lymphocyte Levels<br />

In 21 pts. with iron deficiency anemia, the mean<br />

number <strong>of</strong> total lymphocytes, CD3 and CD4<br />

subsets, and B lymphocytes were decreased, as<br />

was killer cell activity. After iron treatment, some <strong>of</strong><br />

these parameters re t u rned to normal [Santos PC,<br />

Falcado RP. Decreased lymphocyte subsets and K-<br />

cell activity in iron-deficiency anemia. Acta<br />

Haematol 84:118-21, 1990].<br />

I ron Metabolism Abnormalities and Oxidative<br />

Stress<br />

<strong>AIDS</strong> pro g ression in the advanced stage <strong>of</strong> the<br />

infection is accompanied by increasing body iro n<br />

stores. Iron burden is especially heavy in the bone<br />

m a r ro w, brain white matter, muscle and liver.<br />

Excess iron may enhance oxidative stress by<br />

impairing an already compromised immune<br />

system. The reduction and prevention <strong>of</strong> iro n<br />

loading might slow the pro g ression <strong>of</strong> the infectious<br />

complications <strong>of</strong> <strong>AIDS</strong> and possibly <strong>AIDS</strong><br />

itself. Limiting iron intake from any route and the<br />

use <strong>of</strong> iron chelating drugs may decrease the iron<br />

b u rden and possibly suppress the growth <strong>of</strong><br />

m i c ro o rganisms. [Altered Iron Metabolism in <strong>HIV</strong><br />

Infection: Mechanisms, Possible Consequences,<br />

and Proposals For Management. Boelaert, Johan,<br />

R., et al, Infectious Agents and Disease, 1996;5:36-<br />

46. Address: Dr. J.R. Boelaert, Algemeen,<br />

Ziekenhuis Sint Jan., Unit For Renal and Infectious<br />

Disease, Ruddershove 10, 8000 Brugge, Belgium].<br />

Lead and Immune Function<br />

Results <strong>of</strong> animal studies suggest that chronic lowlevel<br />

exposure to lead can greatly depress immune<br />

system function [Bendick A, Belisle EH, Strausser<br />

HR. Immune response <strong>of</strong> rats chronically fed<br />

subclinical doses <strong>of</strong> lead. Clin Exp Immunol<br />

43:189-94, 1981; Blakey BR, Archer DL. The effect<br />

<strong>of</strong> lead acetate on the immune response in mice.<br />

Toxicol Appl Pharmacol 61:18-26, 1981; Faith RE,<br />

Luster MI, Kimmel CA. Effect <strong>of</strong> chronic developmental<br />

lead exposure on cell-mediated immune<br />

functions. Clin Exp Immunol 35:413-20, 1979;<br />

Luster MI, Faith RE, Kimmel CA. Depression <strong>of</strong><br />

humoral immunity in rats following chronic developmental<br />

lead exposure. J Environ Pathol To x i c o l<br />

1:397-402, 1978; Neilman BA, Taddeini L, McJilton<br />

CE, Handwerger BS. Decreased T-cell function in<br />

47<br />

CONTINUUM vol 6, no 1/2

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!